<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li Y</submitter><funding>Natural Science Foundation of Guangdong Province</funding><funding>Science and Technology Planning Project of Shenzhen Municipality</funding><pagination>873</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11274912</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(7)</volume><pubmed_abstract>Guanylate binding protein 5 (GBP5) is an emerging immune component that has been increasingly recognized for its involvement in autoimmune diseases, particularly inflammatory bowel disease (IBD). IBD is a complex disease involving inflammation of the gastrointestinal tract. Here, we explored the functional significance of GBP5 using &lt;i>Gbp5&lt;/i> knockout mice and wildtype mice exposed to dextran sulfate sodium (DSS) to generate chronic colitis model. We found that &lt;i>Gbp5&lt;/i> deficiency protected mice from DSS-induced chronic colitis. Transcriptome analysis of colon tissues showed reduced immune responses in &lt;i>Gbp5&lt;/i> knockout mice compared to those in corresponding wildtype mice. We further observed that after repeated DSS exposure, the gut microbiota was altered, both in wildtype mice a</pubmed_abstract><journal>Biomolecules</journal><pubmed_title>Diminished Immune Response and Elevated Abundance in Gut Microbe Dubosiella in Mouse Models of Chronic Colitis with GBP5 Deficiency.</pubmed_title><pmcid>PMC11274912</pmcid><funding_grant_id>2021A1515012478</funding_grant_id><funding_grant_id>JCYJ20190807160411245</funding_grant_id><pubmed_authors>Hou L</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Wang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Diminished Immune Response and Elevated Abundance in Gut Microbe Dubosiella in Mouse Models of Chronic Colitis with GBP5 Deficiency.</name><description>Guanylate binding protein 5 (GBP5) is an emerging immune component that has been increasingly recognized for its involvement in autoimmune diseases, particularly inflammatory bowel disease (IBD). IBD is a complex disease involving inflammation of the gastrointestinal tract. Here, we explored the functional significance of GBP5 using &lt;i>Gbp5&lt;/i> knockout mice and wildtype mice exposed to dextran sulfate sodium (DSS) to generate chronic colitis model. We found that &lt;i>Gbp5&lt;/i> deficiency protected mice from DSS-induced chronic colitis. Transcriptome analysis of colon tissues showed reduced immune responses in &lt;i>Gbp5&lt;/i> knockout mice compared to those in corresponding wildtype mice. We further observed that after repeated DSS exposure, the gut microbiota was altered, both in wildtype mice a</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2025-08-27T03:11:00.875Z</modification><creation>2025-08-27T03:11:00.875Z</creation></dates><accession>S-EPMC11274912</accession><cross_references><pubmed>39062588</pubmed><doi>10.3390/biom14070873</doi></cross_references></HashMap>